{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T21:33:40Z","timestamp":1722893620757},"reference-count":9,"publisher":"Wiley","issue":"1p2","license":[{"start":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T00:00:00Z","timestamp":1048809600000},"content-version":"vor","delay-in-days":86,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p> <jats:bold>KONZ, K.\u2010H.,<\/jats:bold>\n          <jats:sc>\n            <jats:bold>et al<\/jats:bold>\n          <\/jats:sc>\n          <jats:bold>.: The Influence of Concomitant Drug Therapy on the Efficacy of Atrial Overdrive Stimulation for Prevention of Atrial Tachyarrhythmias.<\/jats:bold>\n          <jats:italic>Data from the completed \u201cSuppression of Atrial Fibrillation by DDD+ Overdrive Pacing with Inos<jats:sup>2<\/jats:sup> CLS (closed\u2010loop system) Pacemakers\u201d multicenter trial were retrospectively evaluated to examine the influence of concomitant antiarrhythmic drugs on the clinical success of conventional single site right atrial overdrive pacing compared with DDD pacing. The DDD+ overdrive algorithm provided &gt;90% atrial pacing at a rate slightly above the intrinsic atrial rate. Seventy\u2010five patients with conventional pacing indications and paroxysmal, recurrent atrial tachyarrhythmia have completed the study. They were randomized to 6 months of DDD or DDD+ pacing, followed by mode crossover and an additional 6\u2010month follow\u2010up in the alternate mode. The incidence of atrial tachyarrhythmia during each period was compared using data on sustained (&gt;60 s) mode switch episodes stored in the pacemaker memory. A stable antiarrhythmic drug regimen was allowed during the study. \u03b2\u2010Adrenergic blockers and Class III antiarrhythmics, prescribed to 54.7% and 40.0% of patients respectively, were linked to minimal or no benefit of overdrive pacing compared with DDD pacing. In contrast, patients untreated with \u03b2\u2010adrenergic blockers or Class III drugs had a significant reduction in atrial tachyarrhythmia burden of &gt;5 hours\/patient per week<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(P &lt; 0.05)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>during overdrive. Changes with Class I and Class IV antiarrhythmic drugs, prescribed to 18.7% and 13.3% of patients, respectively, were insignificant. Our data indicate that clinical trials that prohibit the use of \u03b2\u2010adrenergic blockers may record more favorable outcomes with dynamic atrial overdrive algorithms versus conventional DDDR pacing, than studies allowing concomitant \u03b2\u2010adrenergic blockade. (PACE 2003; 26[Pt. II]:272\u2013277)<\/jats:italic> <\/jats:p>","DOI":"10.1046\/j.1460-9592.2003.00031.x","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T08:02:53Z","timestamp":1104220973000},"page":"272-277","source":"Crossref","is-referenced-by-count":1,"title":["The Influence of Concomitant Drug Therapy on the Efficacy of Atrial Overdrive Stimulation for Prevention of Atrial Tachyarrhythmias"],"prefix":"10.1111","volume":"26","author":[{"given":"KARL\u2010HEINZ","family":"KONZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DEJAN","family":"DANILOVIC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHANNES","family":"BRACHMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PATRICK","family":"ATTUEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DIA EL","family":"ALLAF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CORNELIA","family":"JOHN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KLAUS","family":"MALINOWSKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ULRICH LE","family":"BLANC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ISTVAN","family":"SZENDEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VOLKER","family":"SCHIBGILLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"THOMAS","family":"MOTZKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the\u201cSuppression of Atrial Fibrillation by DDD+ Overdrive Pacing with Inos CLS Pacemakers\u201dstudy investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,3,28]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"104","article-title":"on behalf of the \u201cSuppression of Atrial Fibrillation by DDD+ Overdrive Pacing with Inos2 CLS Pacemakers\u201d study investigators. Therapy and prevention of atrial fibrillation by overdrive stimulation","volume":"20","author":"Attuel P","year":"2000","journal-title":"Herzschrittmacher"},{"key":"e_1_2_7_3_2","first-page":"269","article-title":"Efficacy of DDD+ mode in the prevention of paroxysmal atrial tachyarrhythmias: Interim results of a multicenter European study","volume":"6","author":"Konz KH","year":"2001","journal-title":"Prog Biomed Res"},{"key":"e_1_2_7_4_2","first-page":"221","volume-title":"Drugs for the Heart","author":"Camm AJ","year":"2001"},{"key":"e_1_2_7_5_2","first-page":"1","volume-title":"Drugs for the Heart","author":"Opie LH","year":"2001"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2983"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00489-6"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1994.tb03782.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009801706928"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2517"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1460-9592.2003.00031.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1460-9592.2003.00031.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:58:32Z","timestamp":1697198312000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1460-9592.2003.00031.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":9,"journal-issue":{"issue":"1p2","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1046\/j.1460-9592.2003.00031.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1460-9592.2003.00031.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"type":"print","value":"0147-8389"},{"type":"electronic","value":"1540-8159"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}